Amram O, Amiri S, Panwala V, Lutz R, Joudry P, Socías ME The impact of relaxation of methadone take-home protocols on treatment outcomes in the COVID-19 era Am J Drug Alcohol Abuse PubMed

Shearer D, Young S, Fairbairn N, Brar R Challenges with buprenorphine inductions in the context of the fentanyl overdose crisis: a case series Drug Alcohol Rev PubMed

Douglas S, Hayashi K, Richardson L, DeBeck K, Kerr T Social-structural predictors of fentanyl exposure among street involved youth Subst Use Misuse PubMed

Argento E, Socías ME, Hayashi K, Choi JC, Mackay L, Christie D, Milloy MJ, DeBeck K Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting Int J Drug Policy PubMed

van Draanen J, Tsang C, Mitra S, Phuong V, Murakami A, Karamouzian M, Richardson L Mental disorder and opioid overdose: a systematic review Soc Psychiatry Psychiatr Epidemiol PubMed

Lake S, Kerr T, Buxton J, Walsh Z, Cooper ZD, Socías ME, Fairbairn N, Hayashi K, Milloy MJ The cannabis-dependent relationship between methadone treatment dose and illicit opioid use in a community-based cohort of people who use drugs Cannabis Cannabinoid Res PubMed

Gagliano N, Black S, Mniszak C, Morgan J, Lachowsky N, Knight R Exchanging a "gnawing thought" for "taking a pill once a day": Examining sexual minority men's experiences with PrEP and mental health in a universal PrEP access context AIDS Educ Prev PubMed

Ryan A, Sereda A, Fairbairn N Measures to support a safer drug supply CMAJ PubMed

Tobias S, Lysyshyn M, Buxton J, Tupper KW, Ti L Tobias et al. respond to "Novel surveillance of the unregulated drug supply" Am J Epidemiol PubMed

Poteryko S, Nolan S, Mihic T, Ti L Moving away from a "one size fits all" model: ensuring opioid stewardship includes people who use drugs J Addict Med PubMed